Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

AZN US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

AZN US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Astrazeneca Plc(AZN US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Astrazeneca Plc(AZN US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings by Owner

SEC Filings by Owner

Insider Ownership

ASTRAZENECA PLC(15)

  • Form 4Statement of changes in beneficial ownership16 Mar 2021
  • Form 3Initial statement of beneficial ownership7 Feb 2020
  • Form 4Statement of changes in beneficial ownership7 Feb 2020
  • Form 4Statement of changes in beneficial ownership9 Oct 2019
  • Form 3Initial statement of beneficial ownership2 Oct 2019
  • Form 3/AInitial statement of beneficial ownership (amendment)9 Oct 2019
  • Form 4Statement of changes in beneficial ownership24 Oct 2018
  • Form 3Initial statement of beneficial ownership17 Oct 2018
  • Form 4Statement of changes in beneficial ownership2 Oct 2018
  • Form 3Initial statement of beneficial ownership25 Sep 2018

Sharma Mani(9)

  • Form 4PRIMARY DOCUMENT10 Nov
  • Form 4PRIMARY DOCUMENT8 Oct
  • Form 4OWNERSHIP DOCUMENT11 Sep
  • Form 4PRIMARY DOCUMENT7 Aug
  • Form 4OWNERSHIP DOCUMENT8 Jul
  • Form 4OWNERSHIP DOCUMENT16 Jun
  • Form 4OWNERSHIP DOCUMENT22 May
  • Form 4OWNERSHIP DOCUMENT8 May
  • Form 3OWNERSHIP DOCUMENT19 Mar

ASTRAZENECA AB(6)

  • Form 4Statement of changes in beneficial ownership2 Oct 2018
  • Form 3Initial statement of beneficial ownership25 Sep 2018
  • Form 4Statement of changes in beneficial ownership5 Dec 2017
  • Form 3Initial statement of beneficial ownership7 Nov 2016
  • Form 4Statement of changes in beneficial ownership14 Nov 2014
  • Form 3Initial statement of beneficial ownership12 Oct 2012

AstraZeneca UK LTD(3)

  • Form 4Statement of changes in beneficial ownership16 Mar 2021
  • Form 4Statement of changes in beneficial ownership9 Oct 2019
  • Form 3/AInitial statement of beneficial ownership (amendment)9 Oct 2019

Zeneca, Inc.(2)

  • Form 4Statement of changes in beneficial ownership24 Oct 2018
  • Form 3Initial statement of beneficial ownership17 Oct 2018

MedImmune Ltd(2)

  • Form 3Initial statement of beneficial ownership7 Feb 2020
  • Form 4Statement of changes in beneficial ownership7 Feb 2020

≥5% Ownership

ASTRAZENECA PLC(37)

  • SC 13G/AMonopar Therapeutics6 Feb
  • SC 13D/AInnate Pharma SA6 Feb
  • SC 13G/AConduit Pharmaceuticals Inc.10 Apr 2025
  • SC 13D/ACellectis S.A.24 Jan 2025
  • SC 13GMonopar Therapeutics28 Oct 2024
  • SC 13GConduit Pharmaceuticals Inc.11 Oct 2024
  • SC 13G/AADC Therapeutics SA12 Feb 2024
  • SC 13D/ACellectis S.A.16 Nov 2023
  • SC 13DCellectis S.A.9 Nov 2023
  • SC 13G/APieris Pharmaceuticals, Inc.10 Feb 2023

BlackRock Inc.(17)

  • SC 13G/AAstrazeneca Plc24 Jan 2024
  • SC 13G/AAstrazeneca Plc24 Jan 2023
  • SC 13GAstrazeneca Plc8 Jul 2022
  • SC 13G/AAstrazeneca Plc7 Feb 2022
  • SC 13G/AAstrazeneca Plc29 Jan 2021
  • SC 13G/AAstrazeneca Plc5 Feb 2020
  • SC 13G/AAstrazeneca Plc4 Feb 2019
  • SC 13G/AAstrazeneca Plc30 Jan 2018
  • SC 13G/AAstrazeneca Plc19 Jan 2017
  • SC 13G/AAstrazeneca Plc10 Feb 2016

WELLINGTON MANAGEMENT GROUP LLP(8)

  • SC 13G/AAstrazeneca Plc4 Feb 2022
  • SC 13G/AAstrazeneca Plc3 Feb 2021
  • SC 13G/AAstrazeneca Plc27 Jan 2020
  • SC 13G/AAstrazeneca Plc12 Feb 2019
  • SC 13G/AAstrazeneca Plc8 Feb 2018
  • SC 13G/AAstrazeneca Plc9 Feb 2017
  • SC 13G/AAstrazeneca Plc11 Feb 2016
  • SC 13GAstrazeneca Plc12 Feb 2015

CAPITAL RESEARCH & MANAGEMENT CO(7)

  • SC 13G/AAstrazeneca Plc13 Feb 2008
  • SC 13G/AAstrazeneca Plc12 Feb 2007
  • SC 13G/AAstrazeneca Plc10 Feb 2006
  • SC 13G/AAstrazeneca Plc11 Feb 2005
  • SC 13G/AAstrazeneca Plc13 Feb 2004
  • SC 13G/AAstrazeneca Plc13 Feb 2003
  • SC 13GAstrazeneca Plc15 Feb 2002

CAPITAL GROUP INTERNATIONAL INC(6)

  • SC 13G/AAstrazeneca Plc12 Feb 2008
  • SC 13G/AAstrazeneca Plc12 Feb 2007
  • SC 13G/AAstrazeneca Plc9 Feb 2006
  • SC 13G/AAstrazeneca Plc11 Feb 2005
  • SC 13G/AAstrazeneca Plc13 Feb 2004
  • SC 13GAstrazeneca Plc11 Feb 2003

MERRILL LYNCH & CO INC(2)

  • SC 13G/AAstrazeneca Plc4 Feb 2000
  • SC 13GZeneca Group Plc5 Feb 1999

INVESTOR AB(2)

  • SC 13D/AAstrazeneca Plc17 Feb 2004
  • SC 13DAstrazeneca Plc8 Jul 2002

BlackRock, Inc.(1)

  • SC 13G/AAstrazeneca Plc23 Apr 2025

VANGUARD CAPITAL MANAGEMENT LLC(1)

  • SC 13GAstrazeneca Plc28 Apr

Insider Ownership

ASTRAZENECA PLC(15)

  • Form 4Statement of changes in beneficial ownership16 Mar 2021
  • Form 3Initial statement of beneficial ownership7 Feb 2020
  • Form 4Statement of changes in beneficial ownership7 Feb 2020
  • Form 4Statement of changes in beneficial ownership9 Oct 2019
  • Form 3Initial statement of beneficial ownership2 Oct 2019
  • Form 3/AInitial statement of beneficial ownership (amendment)9 Oct 2019
  • Form 4Statement of changes in beneficial ownership24 Oct 2018
  • Form 3Initial statement of beneficial ownership17 Oct 2018
  • Form 4Statement of changes in beneficial ownership2 Oct 2018
  • Form 3Initial statement of beneficial ownership25 Sep 2018

Sharma Mani(9)

  • Form 4PRIMARY DOCUMENT10 Nov
  • Form 4PRIMARY DOCUMENT8 Oct
  • Form 4OWNERSHIP DOCUMENT11 Sep
  • Form 4PRIMARY DOCUMENT7 Aug
  • Form 4OWNERSHIP DOCUMENT8 Jul
  • Form 4OWNERSHIP DOCUMENT16 Jun
  • Form 4OWNERSHIP DOCUMENT22 May
  • Form 4OWNERSHIP DOCUMENT8 May
  • Form 3OWNERSHIP DOCUMENT19 Mar

ASTRAZENECA AB(6)

  • Form 4Statement of changes in beneficial ownership2 Oct 2018
  • Form 3Initial statement of beneficial ownership25 Sep 2018
  • Form 4Statement of changes in beneficial ownership5 Dec 2017
  • Form 3Initial statement of beneficial ownership7 Nov 2016
  • Form 4Statement of changes in beneficial ownership14 Nov 2014
  • Form 3Initial statement of beneficial ownership12 Oct 2012

AstraZeneca UK LTD(3)

  • Form 4Statement of changes in beneficial ownership16 Mar 2021
  • Form 4Statement of changes in beneficial ownership9 Oct 2019
  • Form 3/AInitial statement of beneficial ownership (amendment)9 Oct 2019

Zeneca, Inc.(2)

  • Form 4Statement of changes in beneficial ownership24 Oct 2018
  • Form 3Initial statement of beneficial ownership17 Oct 2018

MedImmune Ltd(2)

  • Form 3Initial statement of beneficial ownership7 Feb 2020
  • Form 4Statement of changes in beneficial ownership7 Feb 2020

≥5% Ownership

ASTRAZENECA PLC(37)

  • SC 13G/AMonopar Therapeutics6 Feb
  • SC 13D/AInnate Pharma SA6 Feb
  • SC 13G/AConduit Pharmaceuticals Inc.10 Apr 2025
  • SC 13D/ACellectis S.A.24 Jan 2025
  • SC 13GMonopar Therapeutics28 Oct 2024
  • SC 13GConduit Pharmaceuticals Inc.11 Oct 2024
  • SC 13G/AADC Therapeutics SA12 Feb 2024
  • SC 13D/ACellectis S.A.16 Nov 2023
  • SC 13DCellectis S.A.9 Nov 2023
  • SC 13G/APieris Pharmaceuticals, Inc.10 Feb 2023

BlackRock Inc.(17)

  • SC 13G/AAstrazeneca Plc24 Jan 2024
  • SC 13G/AAstrazeneca Plc24 Jan 2023
  • SC 13GAstrazeneca Plc8 Jul 2022
  • SC 13G/AAstrazeneca Plc7 Feb 2022
  • SC 13G/AAstrazeneca Plc29 Jan 2021
  • SC 13G/AAstrazeneca Plc5 Feb 2020
  • SC 13G/AAstrazeneca Plc4 Feb 2019
  • SC 13G/AAstrazeneca Plc30 Jan 2018
  • SC 13G/AAstrazeneca Plc19 Jan 2017
  • SC 13G/AAstrazeneca Plc10 Feb 2016

WELLINGTON MANAGEMENT GROUP LLP(8)

  • SC 13G/AAstrazeneca Plc4 Feb 2022
  • SC 13G/AAstrazeneca Plc3 Feb 2021
  • SC 13G/AAstrazeneca Plc27 Jan 2020
  • SC 13G/AAstrazeneca Plc12 Feb 2019
  • SC 13G/AAstrazeneca Plc8 Feb 2018
  • SC 13G/AAstrazeneca Plc9 Feb 2017
  • SC 13G/AAstrazeneca Plc11 Feb 2016
  • SC 13GAstrazeneca Plc12 Feb 2015

CAPITAL RESEARCH & MANAGEMENT CO(7)

  • SC 13G/AAstrazeneca Plc13 Feb 2008
  • SC 13G/AAstrazeneca Plc12 Feb 2007
  • SC 13G/AAstrazeneca Plc10 Feb 2006
  • SC 13G/AAstrazeneca Plc11 Feb 2005
  • SC 13G/AAstrazeneca Plc13 Feb 2004
  • SC 13G/AAstrazeneca Plc13 Feb 2003
  • SC 13GAstrazeneca Plc15 Feb 2002

CAPITAL GROUP INTERNATIONAL INC(6)

  • SC 13G/AAstrazeneca Plc12 Feb 2008
  • SC 13G/AAstrazeneca Plc12 Feb 2007
  • SC 13G/AAstrazeneca Plc9 Feb 2006
  • SC 13G/AAstrazeneca Plc11 Feb 2005
  • SC 13G/AAstrazeneca Plc13 Feb 2004
  • SC 13GAstrazeneca Plc11 Feb 2003

MERRILL LYNCH & CO INC(2)

  • SC 13G/AAstrazeneca Plc4 Feb 2000
  • SC 13GZeneca Group Plc5 Feb 1999

INVESTOR AB(2)

  • SC 13D/AAstrazeneca Plc17 Feb 2004
  • SC 13DAstrazeneca Plc8 Jul 2002

BlackRock, Inc.(1)

  • SC 13G/AAstrazeneca Plc23 Apr 2025

VANGUARD CAPITAL MANAGEMENT LLC(1)

  • SC 13GAstrazeneca Plc28 Apr